Skip to content

Clinical trials

Terminated Neuroectodermal Tumors, Primitive, Peripheral trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Status: Terminated Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20091
20101
20161
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AeRang Kim1
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Gradalis, Inc.1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
UNC Lineberger Comprehensive Cancer Center1
University of South Florida1
Y-mAbs Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral10
Sarcoma9
Osteosarcoma7
Neuroblastoma6
Wilms Tumor5
Carcinoma, Renal Cell4
Central Nervous System Neoplasms4
Medulloblastoma4
Neoplasms4
Rhabdoid Tumor4

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.